FURMAN et al. V. BELLEAU et al. - Page 9






                                            0                                                                           

                                HOI                                                                                     

                                               N 4ý11                                                                   
                                                  NH2                                                                   





                          which is substantially free of the corresponding (+)-enantiomer, or                           
                          a pharmaceutically acceptable salt, ester or salt of an ester thereof                         
                                                   Redeclaration                                                        
             12. Based on our decision on preliminary motions, the interference was redeclared                          
                   provisionally adding count 2 and count 3 (Paper 66).                                                 
             13. In the redeclaration the following claims were designated as corresponding to count 1:                 
                          Furman: 1-3 and 5                                                                             
                          Belleau'246: 1-3 and 6-9                                                                      
                          Belleau'431: 1-3 and 6-10, 12, and 14                                                         
                   and the following claims were designated as corresponding to count 2 and count 3:                    
                          Furman: 4                                                                                     
                          Belleau'246: 4-9                                                                              
                          Belleau '431: 4-9, 11, 13, and 15                                                             



                                                         9                                                              







Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007